MyoKardia Inc.

1000 Sierra Point Parkway
- Brisbane,  CA  94005

United States
  • Booth: 3707

MyoKardia is a clinical-stage biopharmaceutical company discovering and developing targeted therapies for the treatment of serious cardiovascular diseases. MyoKardia’s initial focus is on small molecule therapeutics aimed at the myocardium to address diseases driven by excessive contraction, impaired relaxation, or insufficient contraction.

 Additional Info

ACC.21 Learning Pathways? (select all that apply)
Heart Failure and Cardiomyopathies